Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Compare that to stopping prescription GLP-1 medication, where weight regain is well-documented
Nearly all PCOS patients prescribed semaglutide or tirzepatide also had obesity or type 2 diabetes, suggesting use remains primarily tied to metabolic indications, though broader interest in PCOS benefits is growing within scientific literature
Health coaches receive specific training in GLP-1 side effect management
Current formulations often suffer from poor solubility and stability, limiting their therapeutic efficacy
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
US$ 27.79
US$ 20.46
US$ 27.56
US$ 23.84
